## **Core Concept**
Von Gierke's disease, also known as Glycogen Storage Disease Type I (GSD I), is a genetic disorder caused by the deficiency of an enzyme involved in glycogen metabolism. This condition leads to an inability to convert glycogen to glucose for energy, resulting in severe hypoglycemia and other metabolic complications.

## **Why the Correct Answer is Right**
The correct answer, **Glucose-6-phosphatase**, is the enzyme deficient in Von Gierke's disease. This enzyme plays a crucial role in the final steps of gluconeogenesis and glycogenolysis, catalyzing the conversion of glucose-6-phosphate to glucose, which can then be released into the bloodstream to maintain blood glucose levels. A deficiency in glucose-6-phosphatase impairs this process, leading to the characteristic features of the disease, including hypoglycemia, lactic acidosis, and hepatomegaly.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify the correct enzyme related to Von Gierke's disease.
- **Option B:** This option is incorrect as it does not accurately represent the enzyme deficient in Von Gierke's disease.
- **Option D:** This option is incorrect because it refers to another enzyme, **debranching enzyme**, which is involved in a different type of glycogen storage disease (GSD III), not Von Gierke's disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical feature of Von Gierke's disease is the presence of **hepatomegaly** (enlarged liver) due to glycogen accumulation, and patients often experience **severe hypoglycemia**, which can lead to seizures and other complications if not properly managed. Early diagnosis and dietary management are crucial for improving the quality of life and prognosis for individuals with this condition.

## **Correct Answer:** . Glucose-6-phosphatase